Key result
Rare ANGPTL7 variants decrease secreted protein levels, strongly correlating with their intraocular pressure effects.
Why the study?
Rare missense and nonsense variants in ANGPTL7 protect against primary open-angle glaucoma, but the functional mechanism remains uncharacterized.
Do protective variants in ANGPTL7 or mechanical stress modulate ANGPTL7 protein expression and secretion in human ocular cells?
Do protective variants in ANGPTL7 or mechanical stress modulate ANGPTL7 protein expression and secretion in human ocular cells?
Answers are grounded in this paper and cite their sources.
Downregulation of ANGPTL7 expression, driven by protective genetic variants or physiologic stress, may serve as a preventative and therapeutic strategy for primary open-angle glaucoma.
Rare missense and nonsense variants in the Angiopoietin-like 7 (ANGPTL7) gene confer protection from primary open-angle glaucoma (POAG), though the functional mechanism remains uncharacterized. Interestingly, a larger variant effect size strongly correlates with in silico predictions of increased protein instability (r = -0.98), suggesting that protective variants lower ANGPTL7 protein levels. Here, we show that missense and nonsense variants cause aggregation of mutant ANGPTL7 protein in the endoplasmic reticulum (ER) and decreased levels of secreted protein in human trabecular meshwork (TM) cells; a lower secreted:intracellular protein ratio strongly correlates with variant effects on intraocular pressure (r = 0.81). Importantly, accumulation of mutant protein in the ER does not increase expression of ER stress proteins in TM cells (P > 0.05 for all variants tested). Cyclic mechanical stress, a glaucoma-relevant physiologic stressor, also significantly lowers ANGPTL7 expression in primary cultures of human Schlemm's canal (SC) cells (-2.4-fold-change, P = 0.01). Collectively, these data suggest that the protective effects of ANGPTL7 variants in POAG stem from lower levels of secreted protein, which may modulate responses to physiologic and pathologic ocular cell stressors. Downregulation of ANGPTL7 expression may therefore serve as a viable preventative and therapeutic strategy for this common, blinding disease.
No takes yet. Share an insight, caveat, or question.
Aboobakar et al. (2023) studied Primary open-angle glaucoma (POAG). Rare missense and nonsense variants in the ANGPTL7 gene was evaluated on Correlation between secreted:intracellular protein ratio and variant effects on intraocular pressure (r = 0.81). Rare missense and nonsense variants in the ANGPTL7 gene decrease secreted protein levels, which strongly correlates with variant effects on intraocular pressure (r = 0.81).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: